載入...

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

BACKGROUND: Biomarkers that can be used to accurately assess the residual risk of disease recurrence in women with hormone receptor–positive breast cancer are clinically valuable. We evaluated the prognostic value of the Breast Cancer Index (BCI), a continuous risk index based on a combination of HO...

全面介紹

Na minha lista:
書目詳細資料
發表在:Breast Cancer Res
Main Authors: Sgroi, Dennis C., Chapman, Judy-Anne W., Badovinac-Crnjevic, T., Zarella, Elizabeth, Binns, Shemeica, Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Pritchard, Kathleen I., Han, Lei, Shepherd, Lois E., Goss, Paul E., Pollak, Michael
格式: Artigo
語言:Inglês
出版: BioMed Central 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4700696/
https://ncbi.nlm.nih.gov/pubmed/26728744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0660-6
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!